SCHEMBL24739320

SCHEMBL24739320

c1ccc(-c2cc(-n3c4ccccc4c4c5ccccc5ccc43)c3oc4cccc(-c5nc(-c6ccccc6)nc(-c6ccc7ccccc7c6)n5)c4c3c2)cc1

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.31
MAPT P10636 2/20 0.31
KDM4E B2RXH2 2/20 0.31
TP53 P04637 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
HSD17B10 Q99714 2/20 0.31
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31
KMT2A Q03164 1/20 0.31
HPGD P15428 1/20 0.30
TSHR P16473 1/20 0.30
NFKB1 P19838 1/20 0.30
MAPK1 P28482 1/20 0.30
NFKB2 Q00653 1/20 0.30
RELA Q04206 1/20 0.30
ATM Q13315 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24738361 0.97 ALDH1A1 (0.32) ALDH1A1MAPTKDM4ETP53SMN1; SMN2
SCHEMBL24738842 0.95 TSHR (0.33) ALDH1A1MAPTKDM4ETP53SMN1; SMN2
SCHEMBL24738918 0.94 ALDH1A1 (0.33) ALDH1A1MAPTKDM4ETP53SMN1; SMN2
SCHEMBL23740510 0.93 ALDH1A1 (0.32) ALDH1A1MAPTKDM4ETP53SMN1; SMN2
SCHEMBL24738853 0.93 TSHR (0.32) ALDH1A1MAPTKDM4ETP53SMN1; SMN2
SCHEMBL21862723 0.92 ALDH1A1 (0.32) ALDH1A1MAPTKDM4ETP53SMN1; SMN2
SCHEMBL24739319 0.92 ALDH1A1 (0.33) ALDH1A1MAPTKDM4ETP53SMN1; SMN2
SCHEMBL24738841 0.91 KDM4E (0.31) ALDH1A1MAPTKDM4ETP53SMN1; SMN2
SCHEMBL24738544 0.91 ALDH1A1 (0.34) ALDH1A1MAPTKDM4ETP53SMN1; SMN2
SCHEMBL24738362 0.91 ALDH1A1 (0.34) ALDH1A1MAPTKDM4ETP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220396568-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2022-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220396568-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE CYP1A1, CYP1B1, CRY1 ALDH1A1 23/4885MAPT 1011/4885KDM4E 3329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.